What does it mean for Panlong Pharmaceutical to obtain a US patent?

Enhance the core competitiveness of Panlong Pharmaceutical Company. According to relevant public information, Panlong Pharmaceutical obtained the US patent, which is the progress in the research stage of the research and development of coronavirus 3CL protease inhibitor, a cooperative project between Panlong Pharmaceutical and Shaanxi Medical University, and enhanced the company's core competitiveness. Panlong Company focused on the research and development of traditional Chinese medicine, and obtained two American patents, indicating its innovation and development into western medicine.